NCT03957174View on ClinicalTrials.gov

Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Healthy
Interventions
DRUG

Reboxetine

Single dose used to increase central norepinepherine

DRUG

Rivastigmine

Single dose to increase central acetylcholine

DRUG

Placebo oral tablet

Single dose as control condition

Trial Locations (1)

OX3 7JX

Dept of Psychiatry, University of Oxford, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03957174 - Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans | Biotech Hunter | Biotech Hunter